Sunshine Mandi

PRODUCTS

Mandi® Minoxidil Foam
Mandi® Minoxidil Foam
Mandi® Minoxidil tincture
Mandi® Minoxidil tincture
Laizi® tacrolimus ointment
Laizi® tacrolimus ointment
Laiduofei®  Fexofenadine Hydrochloride Tablets
Laiduofei® Fexofenadine Hydrochloride Tablets
Mandi® Minoxidil Foam
approval number:H20234731
drug specification:60g*1 x Bottle
general name of drugs:Minoxidil Foam
drug classified:noprescription
Mandi® Minoxidil Foam
Mandi® Minoxidil tincture
Approval number:H20010714
drug specification:5%*60ml*1 x Bottle
general name of drugs:Minoxidil tincture
drug classified:noprescription
Mandi® Minoxidil tincture
Laizi® Tacrolimus Ointment
Approval number:H20133243
drug specification:10g:3mg(0.03%)
general name of drugs:Tacrolimus Ointment
drug classified:prescription
Laizi® tacrolimus ointment
Laiduofei® Fexofenadine Hydrochloride Tablets
Approval number:H20060150
drug specification:30mg*28 x pills
general name of drugs:Fexofenadine Hydrochloride Tablets
drug classified:prescription Rx
Laiduofei®  Fexofenadine Hydrochloride Tablets

Sunshine Mandi

Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. (referred to as "Sunshine Mandi"), founded in 1958, is an integrated enterprise engaged in the research, production, and sales of pharmaceuticals. After being incorporated into 3SBio Inc., in 2015, Sunshine Mandi was positioned as "specializing in skin care and excelling in hair treatment. "Upholding the Group's principle of balancing profitability with social responsibility, the company was selected as a supplier for the 19th Asian Games (Paralympics) in Hangzhou in 2023, actively contributing to the development of sports in China.

unshine Mandi's core business focuses on hair loss treatment and dermatology. As a nationally recognized high-tech enterprise, it has been consistently ranked among the "Top Ten Manufacturing Enterprises" in Lin'an District for three consecutive years, designated as a provincial-level "Specialized, Refined, Distinctive, and Innovative" SME, and honored as a "Technology Little Giant" in Zhejiang Province in 2023. Leveraging the Zhejiang Provincial Mandi Hair Key Enterprise Research Institute as a platform, the company integrates resources from the Sunshine Pharmaceutical Group and advances pharmaceutical research and innovation through independent R&D, technology importation, and industry-academia collaboration.

Guided by the corporate values of "integrity and pragmatism, professionalism and dedication, innovation and achievement," Sunshine Mandi aims to become a leading enterprise in the specialized field of hair and skin health, with a strong foundation in China and a vision for the global market.

43495.8

Total Square Metres

52.4

Acre
Construction Land

Development History

1959

1959

● Hangzhou Veterinary Drug Manufacturing Factory
1967

1967

● Hangzhou Biopharmaceutical Factory
1980

1980

● Hangzhou Third Pharmaceutical Factory
1983

1983

● Hangzhou Pharmaceutical Factory
1997

1997

● Zhejiang Wanma Pharmaceutical Co., LTD
2015

2015

● Zhejiang Wansheng Pharmaceutical Co., LTD
2024

2024

● Zhejiang Sunshine Mandi Pharmaceutical Co.,LTD

NEWS

Honor